Namba, T., Sugimoto, Y., Hirata, M., et al. Mouse thromboxane A₂ receptor: cDNA cloning, expression and Northern blot analysis. Biochem Biophys Res Commun 184 1197-1203 (1992).

Wang, G., Zhu, Y., Halushka, P.V., et al. Mechanism of platelet inhibition by nitric oxide: In vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. Proc Natl Acad Sci USA 95 4888-4893 (1998).

Båtshake, B., Nilsson, C., and Sundelin, J. Structure and expression of the murine thromboxane A₂ receptor gene. Biochem Biophys Res Commun 256 391-397 (1999).

Armstrong, R.A. Platelet Prostanoid Receptors. Pharmacotherapy 72 171-191 (1996).

Ellis, E.F., Oelz, O., Roberts, L.J., et al. Coronary arterial smooth muscle contraction by a substance released from platelets: Evidence that it is thromboxane A₂. Science 193 1135-1137 (1976).

Dogné, J., de Leval, X., Benoit, P., et al. Therapeutic potential of thromboxane inhibitors in asthma. Expert Opin Investig Drugs 11(2) 1-8 (2003).

Habib, A., Fitzgerald, G.A., and Maclouf, J. Phosphorylation of the thromboxane receptor α, the predominant isoform expressed in human platelets. J Biol Chem 274 2645-2651 (1999).

Takahashi, N., Takeuchi, K., Abe, T., et al. Immunolocalization of rat thromboxane receptor in the kidney. Endocrinology 137 5170-5173 (1996).

Mais, D.E., True, T.A., and Martinelli, M.J. Characterization by photoaffinity labelling of the human platelet thromboxane A₂/prostaglandin H₂ receptor: Evidence for N-linked glycosylation. Eur J Pharmacol 227 267-274 (1992).

Janssen, L.J., and Tazzeo, T. Involvement of TP and EP₃ receptors in vasoconstrictor responses to isoprostanes in pulmonary vasculature. J Pharmacol Exp Ther 301(3) 1060-1066 (2002).

Cadroy, Y., and Harker, L.A. Platelets, thrombosis, and antithrombotic therapies. 3rd ed. 515-539 (1990).

1 Cadroy, Y., and Harker, L.A. Platelets, thrombosis, and antithrombotic therapies. 3rd ed. 515-539 (1990).

2 Dogné, J., de Leval, X., Benoit, P., et al. Therapeutic potential of thromboxane inhibitors in asthma. Expert Opin Investig Drugs 11(2) 1-8 (2003).

3 Ellis, E.F., Oelz, O., Roberts, L.J., et al. Coronary arterial smooth muscle contraction by a substance released from platelets: Evidence that it is thromboxane A₂. Science 193 1135-1137 (1976).

4 Janssen, L.J., and Tazzeo, T. Involvement of TP and EP₃ receptors in vasoconstrictor responses to isoprostanes in pulmonary vasculature. J Pharmacol Exp Ther 301(3) 1060-1066 (2002).

5 Armstrong, R.A. Platelet Prostanoid Receptors. Pharmacotherapy 72 171-191 (1996).

6 Namba, T., Sugimoto, Y., Hirata, M., et al. Mouse thromboxane A₂ receptor: cDNA cloning, expression and Northern blot analysis. Biochem Biophys Res Commun 184 1197-1203 (1992).

7 Båtshake, B., Nilsson, C., and Sundelin, J. Structure and expression of the murine thromboxane A₂ receptor gene. Biochem Biophys Res Commun 256 391-397 (1999).

8 Mais, D.E., True, T.A., and Martinelli, M.J. Characterization by photoaffinity labelling of the human platelet thromboxane A₂/prostaglandin H₂ receptor: Evidence for N-linked glycosylation. Eur J Pharmacol 227 267-274 (1992).

9 Takahashi, N., Takeuchi, K., Abe, T., et al. Immunolocalization of rat thromboxane receptor in the kidney. Endocrinology 137 5170-5173 (1996).

10 Wang, G., Zhu, Y., Halushka, P.V., et al. Mechanism of platelet inhibition by nitric oxide: In vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. Proc Natl Acad Sci USA 95 4888-4893 (1998).

11 Habib, A., Fitzgerald, G.A., and Maclouf, J. Phosphorylation of the thromboxane receptor α, the predominant isoform expressed in human platelets. J Biol Chem 274 2645-2651 (1999).